Positron Emission Tomography Scanners - Global Strategic Business Report

The global market for Positron Emission Tomography Scanners was valued at US$2.3 Billion in 2025 and is projected to reach US$3.3 Billion by 2032, growing at a CAGR of 5.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Positron Emission Tomography (PET) Scanners Market - Key Trends & Drivers Summarized

Can PET Scanning Transform the Next Era of Diagnostic Precision?

Positron Emission Tomography (PET) scanners are at the forefront of precision imaging, enabling clinicians to visualize metabolic and physiological functions in real-time. Unlike traditional CT or MRI, PET imaging provides insights at the cellular and molecular levels, making it indispensable for detecting early-stage cancers, neurological disorders, and cardiovascular anomalies. With rising incidences of diseases like Alzheimer's and lymphoma, PET scanners are becoming a cornerstone in both diagnostics and treatment planning. These machines are often integrated with CT or MRI systems (PET/CT or PET/MRI), offering hybrid imaging capabilities that enhance diagnostic accuracy and reduce patient exposure to multiple procedures. The ability of PET to assess biological activity allows for targeted therapies and personalized medicine - both rapidly growing fields in oncology and neurology. Recent advancements have enabled the use of novel radiotracers, expanding the range of detectable conditions. Furthermore, as healthcare shifts from reactive to preventative models, PET scanners are finding increased usage in health screening programs and clinical trials. Their growing role in drug development, especially for immunotherapy and neuropharmacology, underscores their diagnostic and prognostic potential.

How Is the Global PET Scanner Market Evolving Across Regions?

The global PET scanner market is undergoing robust expansion, driven by technological improvements, rising chronic disease prevalence, and expanding access to advanced diagnostics. North America holds the largest share, due to the presence of sophisticated healthcare infrastructure, supportive reimbursement policies, and high awareness of early diagnostics. Europe follows closely, with growing adoption in Germany, France, and the UK, where public health systems are increasingly investing in molecular imaging for cancer and brain disorders. Meanwhile, the Asia-Pacific region is witnessing the fastest growth, led by China, Japan, and India, where rising healthcare expenditure, aging populations, and increasing cancer cases are catalyzing market expansion. Government initiatives in these regions, including subsidies for diagnostic imaging and public-private partnerships, are improving access to PET facilities. In emerging markets, mobile PET units and public diagnostic centers are helping bridge the urban-rural imaging gap. Additionally, global diagnostic chains are expanding their reach in tier-2 and tier-3 cities, making PET imaging more accessible. As global awareness around early detection and personalized medicine rises, PET scanner installations are expected to increase steadily in both developed and developing economies.

What Technological Breakthroughs Are Defining the Future of PET Imaging?

Technology is rapidly reshaping the capabilities and applications of PET scanners. Modern scanners now utilize digital detectors instead of traditional photomultiplier tubes, offering higher resolution, faster scan times, and reduced radiation doses. Time-of-flight (TOF) PET technology has dramatically improved image clarity and lesion detectability by accurately measuring the arrival time of photons. Integration with artificial intelligence (AI) and machine learning is enabling automated image interpretation, anomaly detection, and improved workflow efficiency. AI also supports radiomics - extracting large amounts of quantitative data from images to predict outcomes and guide treatment. Radiotracer development is another frontier, with newer agents targeting tau proteins in Alzheimer's, amyloid plaques, prostate-specific membrane antigens (PSMA), and fibroblast activation proteins (FAPs) in various cancers. These specialized tracers allow more targeted disease detection and are transforming PET into a tool for theranostics - combining therapy and diagnostics. Portable and compact PET scanners, especially for brain imaging, are also being developed for use in emergency and outpatient settings. Meanwhile, innovations in hybrid modalities, such as PET/MRI, are facilitating comprehensive diagnostics with reduced scanning time and patient discomfort. These breakthroughs are making PET imaging more powerful, patient-friendly, and accessible across healthcare tiers.

The Growth in the PET Scanners Market Is Driven by Several Factors

The growth in the PET scanners market is driven by several factors directly linked to advanced diagnostics, evolving healthcare models, and innovation in both hardware and tracers. Rising prevalence of chronic and lifestyle-related diseases - especially cancer, neurological conditions, and cardiac disorders - is leading to increased demand for early and precise diagnosis. The expansion of personalized medicine and targeted therapies relies heavily on PET imaging to monitor drug efficacy and tumor response. Technological innovations such as digital PET, AI-driven analytics, and time-of-flight imaging are enhancing image resolution and reducing scan duration, improving patient throughput and diagnostic confidence. The development of novel radiopharmaceuticals tailored to specific disease markers is expanding clinical applications and driving repeat PET procedures. On the demand side, growing patient awareness, broader insurance coverage, and the integration of PET into routine oncology pathways are increasing scan volumes. The rise of clinical research and pharma-sponsored trials also necessitates PET capabilities for biomarker-based assessments. Finally, infrastructure investment - including mobile PET units and scalable imaging suites - is helping meet rising demand in both urban hospitals and rural outreach programs. These aligned drivers are positioning PET scanners as indispensable tools in the future of predictive and precision medicine.

Report Scope

The report analyzes the Positron Emission Tomography Scanners market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

• Segments: Product Type (Full Ring PET Scanner, Partial Ring PET Scanner); Application (Oncology, Cardiology, Neurology, Other Applications); Detector Type (Bismuth Germanium Oxide, Lutetium Oxyorthosilicate, Gadolinium Oxyorthosilicate, Lutetium Fine Silicate, Lutetium Yttrium Orthosilicate); End-User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, Other End-Users).
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Full Ring PET Scanner segment, which is expected to reach US$2.2 Billion by 2032 with a CAGR of a 6.1%. The Partial Ring PET Scanner segment is also set to grow at 3.7% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, valued at $637.1 Million in 2025, and China, forecasted to grow at an impressive 9.2% CAGR to reach $726.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Positron Emission Tomography Scanners Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Positron Emission Tomography Scanners Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Positron Emission Tomography Scanners Market expected to evolve by 2032?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2032?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Agfa-Gevaert, Basda Medical, Canon Medical Systems Corporation, CMR Naviscan, Cubresa Inc. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Positron Emission Tomography Scanners market report include:

• Agfa-Gevaert
• Basda Medical
• Canon Medical Systems Corporation
• CMR Naviscan
• Cubresa Inc.
• GE Healthcare
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Mediso Ltd.
• MinFound Medical Systems
• MR Solutions
• Neusoft Medical Systems
• Oncovision
• Planmeca Oy
• Positron Corporation
• Shimadzu Corporation
• Siemens Healthineers AG
• Spectrum Dynamics Medical
• Toshiba Medical Systems Corporation
• United Imaging Healthcare Co., Ltd.

What Sets This Report Apart From Others?

• Grounded in Domain Expert Perspectives: Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.
• Captures Early Market Signals: Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.
• Draws From a Broad, Validated Intelligence Base: Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.
• Connects Signals With Strategic Market Direction: Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.
• Provides In-Depth Company Intelligence: Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.
• Market Share Is Examined Where It Matters: A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, our reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.